Abstract

Sickle cell anaemia and Glucose-6-phosphate dehydrogenase deficiency have anaemia as major clinical consequence. The two disorders are rarely co-expressed in a patient. However, the pathological co-existence of both disorders tends to worsen and aggravate the clinical presentation in affected individuals. We report a diagnosis of the co-inheritance of these two disorders in a 43 year old man who was diagnosed with SCA at childhood. He was managed in a secondary health care facility since child hood. He has had multiple blood transfusions on account of repeated episodes of haemolytic anaemia which was solely attributed to SCA. He was referenced our center on account of recurrent severe heamolytic anaemia with a PCV of 9%. In the preceding 2 months to detecting his G6PD deficient status, he was having monthly blood transfusions on account of severe anaemia. Following the detection of his G6PD deficiency status and appropriate intervention with glutathione and selenium supplements and counseling to avoid exposure to oxidizing agents, he had a respite in the frequency of acute episodes of haemolysis necessitating blood transfusion, as well as an improvement in his steady state PCV of 16%. This case report underscores the importance of routine screening for G6PD status in patients with SCA so as to institute appropriate measures to reduce the worsening of incidence of acute episodes of haemolysis and the need for recurrent blood transfusions on account of this.

Highlights

  • Glucose-6-phosphate dehydrogenase is the rate limiting enzyme in the pentose phosphate pathway that converts glucose-6-phosphate into 6-phosphogluconate [1]

  • The activity of the pentose phosphate pathway protects red blood cells (RBCs) from oxidative damage by supplying reducing energy to them maintaining the level of reduced co-enzyme nicotinamide adenine dinucleotide phosphate (NADPH) [5]

  • Patrick Olanrewaju Osho et al.: Impact of Glucose-6-phosphate Dehydrogenase Deficiency on Sickle Cell Anaemia Expression: A Case Report in turn maintains the supply of reduced glutathione (GSH) in the RBCs which acts like oxidant scavenger that is used to mop up any oxidants that will cause damage to the RBCs [6]

Read more

Summary

Introduction

Glucose-6-phosphate dehydrogenase is the rate limiting enzyme in the pentose phosphate pathway that converts glucose-6-phosphate into 6-phosphogluconate [1]. This is a case of a 43 years old man, a known sickle cell anaemia patient (HbSS) diagnosed at childhood who was referred from general hospital on account of recurrent passage of coca coke coloured urine, jaundice, severe bone pains and generalized body weakness. His stable PCV was said to be 16%, whenever he had haematuria, his PCV dropped to 9%, this he observed for more than 20 years.

Findings
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.